Medical Footwear Market Size, Share & Trends Analysis Report By End Use (Men, Women), By Distribution Channel (Offline, Online), By Region (North America, Europe, APAC, Central & South America, MEA), And Segment Forecasts, 2020 - 2027

Report Overview

全球医疗鞋类市场规模是有价值的at USD 8.30 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2020 to 2027. The rising number of foot-related issues, such as plantar fasciitis, bunions, arthritis, foot and ankle injuries, corns, and flat feet, on account of poorly fitting shoes, is a key factor driving the market. According to the American Podiatric Medical Association (APMA) 2019, in the U.S., about 77% of Americans have encountered foot disorders and related issues. Usage of ill-fitted shoes for a prolonged period of time for normal walks or running can result in sprains, strains, or trauma in the feet, which can limit the wearers’ mobility to perform day-to-day activities. The longer these conditions are left untreated, the worse the pain and discomfort become for the people. However, growing awareness regarding the benefits of medical footwear among consumers is expected to propel the product demand. These footwear offers cushion to the entire foot, providing it with the support to the wearer to move freely.

Additionally, patients with medical conditions, including diabetes, are among the leading consumers of therapeutic footwear to heal ankle and foot. Inadequately controlled blood sugar in the case of these patients can damage many parts of the body, including the nerves and vessels that go to the feet, which makes them more prone to develop feet problems and a condition called neuropathy. Medical footwear is categorically designed shoes that can help reduce risk and promote healthy blood circulation, mobility, and support to the feet.

根据Diabetes.co。英国,一个全球社区the area of diabetes estimated that close to 415 million people were living with diabetes in the world as of 2019, which is estimated to be 1 in 11 of the world’s adult population. This figure is expected to rise to 642 million people living with diabetes worldwide by 2040. Growing cases of diabetes are expected to eventually boost market growth across the world.

Apart from medical-related issues, long-distance runners, sports enthusiasts, and military combats who perform high-intensity outdoor activities are likely to suffer from knee pain and ankle sprains and require medical footwear to recover feet and heal. Enthused by the opportunity existence, many companies have been focusing on offering footwear designed to appeal to this segment of people. For instance, in May 2020, a startup named Kingetics made a technological innovation in footwear for military combats. The Kignetics mechanical insole system lever has advanced composite insoles that reduce stress fractures and injury rates during training. It is an orthopedic design that incorporates lever and spring plate to reduce the impact of injuries, which is about 16% and shoots up to 30% in infantry units.

在逆境中,冠状病毒潘德mic, there has been a shift in the purchasing pattern of the consumers. According to a Vertical Web Media report, online sales have surged during the lockdown period. However, the demand for essential products, such as groceries, medicines, and other food items, is dominating customer requirements. Consumers have become more conscious of their spending habits and are avoiding buying non-essential products, thereby declining the growth for the footwear industry, including medical footwear, among consumers.

End-use Insights

The men segment led the market and accounted for 57.2% share of the global revenue in 2019. Increasing cases of medical conditions, including diabetics, among men have been driving the segment. According to Diabetes.co.uk, men accounted for close to 56% of the U.K. adults with diabetes in 2019. Similarly, according to the U.S. National Library of Medicine, globally, more males are diagnosed with diabetes compared to women annually. Increasing diabetic patients are expected to have a positive impact on the growth of the segment during the forecast period.

The women segment is expected to register the fastest CAGR of 5.9% from 2020 to 2027. Increasing outdoor activities, running, climbing, and other adventure activities among women are likely to drive demand for medical footwear to prevent knee pain and risk of injuries. Established companies have been focusing on research and development to offer appropriate footwear to consumers. For instance, in October 2019, New Balance Athletics, Inc., a sports footwear and apparel manufacturer, collaborated with a medical apparel company FIGS to bring functional and fashionable footwear. 574S is a performance-focused shoe available for women with water-resistant attributes and fresh foam midsoles to offer increased support.

Distribution Channel Insights

Offline distribution channels dominated the market and accounted for 74.9% share of the global revenue in 2019. Trends in the distribution channels for the medical footwear market underscore an increased consumer inclination towards buying these products from offline stores, such as retail outlets and multi-brand outlets. People prefer to buy these products through stores by physically verifying the durability, comfort, and material of thefootwearby trying it. People have become more conscious about the quality of medical footwear, which is one of the main reasons fueling segment growth.

The online distribution channel is expected to witness the fastest growth over the forecast period. The rising popularity ofe-commercechannels is likely to lead to considerable growth prospects for the market owing to a wider distribution network. Such factors have been encouraging manufacturers to sell their products through online channels. The growth of the e-commerce industry globally is expected to change market dynamics in the coming years. Consumers are showing a shift in purchasing patterns, particularly in developed regions such as North America and Europe, with increased shipments of medical footwear purchased through online distribution channels.

Regional Insights

North America dominated the market for medical footwear and accounted for 33.5% share of the global revenue in 2019. Increasing foot-related issues owing to diabetes and sports-related fractures, coupled with established healthcare providers, are among the primary reasons fueling the growth of the regional market. According to WebMD LLC. Report 2019, close to 23,000 people in the U.S. including both athletes and non-athletes, require medical care for ankle sprains per day. Moreover, ankle sprains are found to be one of the most common foot and ankle injuries in active-duty personal in the U.S. Army, with close to 103 sprains per 1000 persons per year. Consumers prefer medical footwear to reduce the impact of pain and do not shy away to pay a premium price for these products.

亚太地区预计将见证gr最快的owth over the forecast period. An increasing number of diabetic patients and rising cases of foot ankle sprains due to outdoor activities are the key factors driving the regional market. According to the International Diabetes Federation report, in 2016, China and India witnessed the highest number of active diabetic cases across the world. Growing concerns among the people regarding health, along with increasing disposable income in these countries, are expected to drive the product demand during the forecast period.

Key Companies & Market Share Insights

The market for medical footwear is fragmented on account of the presence of prominent players at the regional level, especially in the Asia Pacific region with the same end-use offerings. In this respect, key market participants are expected to invest in research & development activities to remain competitive over the forecast period. Some of the prominent players in the medical footwear marketinclude:

• New Balance

• Dr. Comfort

• Mephisto

• Aetrex Worldwide, Inc.

• Orthofeet

• Duna

• Darco International Inc.

• Aetrex Worldwide, Inc.

• Dr. Zen, Inc.

• Gravity Defyer Corp.

Medical Footwear Market Report Scope

Report Attribute	Details
Market size value in 2020	USD 8.12 billion
Revenue forecast in 2027	USD 12.97 billion
Growth Rate	CAGR of 5.7% from 2020 to 2027
Base year for estimation	2019
Historical data	2016 - 2018
Forecast period	2020 - 2027
Quantitative units	Revenue in USD million and CAGR from 2020 to 2027
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	End-use, distribution channel, region
Regional scope	North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
Country scope	U.S.; U.K.; Germany; France; China; India; Brazil
Key companies profiled	New Balance; Dr. Comfort; Mephisto; Aetrex Worldwide, Inc.; Orthofeet; Duna; Darco International Inc.; Aetrex Worldwide, Inc.; Dr. Zen, Inc.; Gravity Defyer Corp.
Customization scope	Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global medical footwear market report on the basis of end-use, distribution channel, and region:

• End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Men

  • Women

• Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

  • Offline

  • Online

• Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

    • The U.S.

  • Europe

    • Germany

    • The U.K.

    • France

  • Asia Pacific

    • China

    • India

  • Central & South America

    • Brazil

  • Middle East & Africa (MEA)